Schedule 13G ownership disclosure

Ultragenyx Pharmaceutical Inc

Security class unavailable · CUSIP: 90400D108

Event date: Unavailable

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
5.2240%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000318989-14-000103
Form type
SC 13G
Filer
FIL Ltd
CIK
CIK 318989
Filed
Aug 11, 2014
Reporting period
—
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub